Inhaled iloprost for patients with precapillary pulmonary hypertension and right-side heart failure

Journal of Cardiac Failure

Volumn 17, Issue 10, 2011, Pages 813-818

  Martischnig, Amadea M ^a   Tichy, Alexander ^b   Nikfardjam, Mariam ^a   Heinz, Gottfried ^a   Lang, Irene M ^a   Bonderman, Diana ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

heart failure; Pulmonary hypertension

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ILOPROST;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART INDEX; HEART RIGHT VENTRICLE FAILURE; HUMAN; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION;

ADMINISTRATION, INHALATION; AGED; BLOOD PRESSURE DETERMINATION; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; TREATMENT OUTCOME; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 80053562268     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2011.05.012     Document Type: Article

References (23)

1. N. Galie, A. Manes, L. Negro, M. Palazzini, M.L. Bacchi-Reggiani, and A. Branzi A meta-analysis of randomized controlled trials in pulmonary arterial hypertension Eur Heart J 30 2009 394 403
2. A. Haraldsson, N. Kieler-Jensen, and S.E. Ricksten Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study J Cardiothorac Vasc Anesth 10 1996 864 868 (Pubitemid 26422479)
3. N. Galie, M.M. Hoeper, M. Humbert, A. Torbicki, J.L. Vachiery, and J.A. Barbera Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J 30 2009 2493 2537
4. V.V. McLaughlin, S.L. Archer, D.B. Badesch, R.J. Barst, H.W. Farber, and J.R. Lindner ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association J Am Coll Cardiol 53 2009 1573 1619
5. M.J. Griffiths, and T.W. Evans Inhaled nitric oxide therapy in adults N Engl J Med 353 2005 2683 2695 (Pubitemid 41817717)
6. M.S. Buckley, and J.P. Feldman Inhaled epoprostenol for the treatment of pulmonary arterial hypertension in critically ill adults Pharmacotherapy 30 2010 728 740
7. C.J. De Wet, D.G. Affleck, E. Jacobsohn, M.S. Avidan, H. Tymkew, and L.L. Hill Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery J Thorac Cardiovasc Surg 127 2004 1058 1067 (Pubitemid 38451939)
8. M.M. Hoeper, H. Olschewski, H.A. Ghofrani, H. Wilkens, J. Winkler, and M.M. Borst A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group J Am Coll Cardiol 35 2000 176 182 (Pubitemid 30061277)
9. H.H. Leuchte, M. Schwaiblmair, R.A. Baumgartner, C.F. Neurohr, T. Kolbe, and J. Behr Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension Chest 125 2004 580 586 (Pubitemid 38223639)
10. A. Limsuwan, S. Wanitkul, A. Khosithset, S. Attanavanich, and P. Samankatiwat Aerosolized iloprost for postoperative pulmonary hypertensive crisis in children with congenital heart disease Int J Cardiol 129 2008 333 338
11. M. Gomberg-Maitland, and H. Olschewski Prostacyclin therapies for the treatment of pulmonary arterial hypertension Eur Respir J 31 2008 891 901
12. H. Olschewski, G. Simonneau, N. Galie, T. Higenbottam, R. Naeije, and L.J. Rubin Inhaled iloprost for severe pulmonary hypertension N Engl J Med 347 2002 322 329 (Pubitemid 34815354)
13. J. Mair Biochemistry of B-type natriuretic peptide - where are we now? Clin Chem Lab Med 46 2008 1507 1514
14. F. Reichenberger, A. Mainwood, N. Doughty, A. Fineberg, N.W. Morrell, and J. Pepke-Zaba Effects of nebulised iloprost on pulmonary function and gas exchange in severe pulmonary hypertension Respir Med 101 2007 217 222 (Pubitemid 46075984)
15. F. Reichenberger, A. Mainwood, N.W. Morrell, J. Parameshwar, and J. Pepke-Zaba Intravenous epoprostenol versus high dose inhaled iloprost for long-term treatment of pulmonary hypertension Pulm Pharmacol Ther 24 2011 169 173
16. T. Gessler, T. Schmehl, M.M. Hoeper, F. Rose, H.A. Ghofrani, and H. Olschewski Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension Eur Respir J 17 2001 14 19 (Pubitemid 32600551)
17. Bayer HealthCare Pharmaceuticals. Ventavis: EPAR - product information. Annex I. Summary of product characteristics. Available at: http://www.ema. europa.eu/docs/en-GB/document-library/EPAR-Product-Information/human/000474/ WC500048691.pdf. Accessed March 10, 2011.
18. N. Doughty, and A. Mainwood Pulmonary hypertension: the role of specialist units Nurs Times 97 2001 54 56
19. J. Denyer, and T. Dyche The Adaptive Aerosol Delivery (AAD) technology: past, present, and future J Aerosol Med Pulm Drug Deliv 23 Suppl 1 2010 S1 S10
20. Wilkinson J, Martin L, Sephton P, Hamilton N, Armstrong I, Elliot CA, et al. Successful conversion of patients using nebulised iloprost from multisonic nebuliser to adaptive aerosol delivery nebuliser: European Respiratory Society, 2007. Available at: https://www.ersnetsecure.org/public/prg-congres.abstract?ww- i-presentation=30910. Accessed March 10, 2011.
21. Bayer HealthCare Pharmaceuticals. Ventavis (iloprost) inhalation solution. Highlights of prescribing information: Actelion. Available at: http://www.4ventavis.com/pdf/Vent-PromoPIUpdate6-10-VV6334.pdf. Accessed March 10, 2011.
22. van Dyke R, Nikander K. Decreased treatment times with aerosolized iloprost following increase in power levels for the I-neb Adaptive Aerosol Delivery (AAD) system: drug delivery to the lungs, 2008. Available at: http://ddl-conference.org.uk/files/posters/31.Nikander.pdf. Accessed March 10, 2011.
23. V.V. McLaughlin, R.J. Oudiz, A. Frost, V.F. Tapson, S. Murali, and R.N. Channick Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension Am J Respir Crit Care Med 174 2006 1257 1263 (Pubitemid 44924827)